Recent Acquisition Alimera Sciences was acquired by ANI Pharmaceuticals, Inc. This change presents an opportunity to explore potential synergies and new business collaborations with the new parent company.
Investment from Deltec Asset Management Deltec Asset Management invested $690K in Alimera Sciences. This financial support indicates investor confidence in the company's growth prospects, potentially opening doors for partnership opportunities or expanded investments.
Equity Inducement Plan Launch Alimera Sciences launched a 2024 Equity Inducement Plan, showcasing a commitment to reward and motivate employees. This initiative signals a positive company culture that can be leveraged to attract top talent and strengthen client relationships.
Recognized Industry Leadership Alimera Sciences was recognized as a top player in the Drug Manufacturers - Specialty & Generic industry. Leveraging this industry recognition can enhance credibility in the market, attract potential investors, and facilitate new business opportunities.
Hiring of Chief Financial Officer Alimera Sciences hired Elliot Maltz as Chief Financial Officer. With a seasoned financial leader on board, there is potential for improved financial strategies, enhanced operational efficiencies, and the ability to pursue strategic partnerships for business expansion.
79
$10M$50M
93K$1B
103K$1B
1.2K$100M$1B
11K$1B
78K$1B
10K$1BAlimera uses 8 technology products and services including Snowplow, MySQL, Dropbox, and more. Explore Alimera's tech stack below.
| Alimera Email Formats | Percentage |
| First.Last@alimerasciences.com | 87% |
| First@alimerasciences.com | 6% |
| FLast@alimerasciences.com | 5% |
| Last@alimerasciences.com | 2% |
Pharmaceutical ManufacturingGeorgia, United States201-500 Employees
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com .
Company Overview
Media & News
Funding & FinancialsAlimera has raised a total of $20M of funding over 11 rounds. Their latest funding round was raised on Apr 14, 2021 in the amount of $20M.
Alimera's revenue is in the range of $10M$50M
Funding & FinancialsAlimera has raised a total of $20M of funding over 11 rounds. Their latest funding round was raised on Apr 14, 2021 in the amount of $20M.
Alimera's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com